In this blog, our changemakers describe how pharmaceutical companies must redefine the field rep role and transform operations to put the healthcare provider at the core. They explore the role of data in shaping the field force of the future.
Search
Filter
- Clear All
- 10 results found
- Life Sciences
- Transformation Management
North Highland Attends Pharma Marketing USA 2022
Global pharma leaders gathered in Philadelphia on November 8th – 9th for Reuters Pharma Marketing USA 2022. Speakers shared insights and experiences that confirm North Highland’s approach to transforming and optimizing pharma marketing organizations.
North Highland’s Amy Turnquist Highlights the Importance of Empathy, Emotion in Creating Experiences in Life Sciences
Amy Turnquist, Life Sciences Principal at North Highland, participated in a conversation about experience at the May 2021 Digital Health Coalition’s Virtual Summit. In a new article, she offers her take on the Summit by capturing insights from experience leaders at AbbVie, Disney Institute, Petco, and more.
Future in Flux: Intel for the Life Sciences Executive
Our December 2021 study probed trends and transformation outlook for the life sciences industry this year and uncovered two critical opportunities: securing the right talent and enabling employees to drive operational excellence.
Future in Flux: Top Life Sciences Trends for 2022
Our December 2021 study probed trends and transformation outlook for the life sciences industry this year and uncovered two critical opportunities: securing the right talent and enabling employees to drive operational excellence.
The Next Vantage for Life Sciences
Our June 2022 survey of 54 life sciences leaders highlighted the importance of a flexible transformation strategy. Yet, successfully executing and delivering on transformation strategy requires more organizational alignment.
Visualize Your Next Vantage: Life Sciences
How can today’s life sciences organizations adapt and respond quickly to what’s next? To find out, we surveyed 54 U.S.-based life sciences leaders in June 2022. More than ever, data shows that the only constant is change for the industry’s leaders. With an unprecedented pandemic response now in the rearview, life sciences leaders understand there is no going back to business as usual. The industry proved it could crush timelines in drug development, collaborate globally, and work cross functionally in ways that traditional organizational structures weren’t designed to support. Now, the expectation has been set.